A new study shows that removing regulatory T cells from tumors helps natural killer cells attack certain cancers that normally evade immune detection in mice. This is one of several emerging immunotherapy approaches showing promise—researchers are increasingly finding ways to reprogram immune cells to overcome tumor resistance. The research is published in Science Immunology but hasn't yet moved to human trials, so the 'could inform future strategies' framing is appropriately cautious about next steps.